podcast
details
.com
Share
Not So Different: A Podcast from The Center for Biosimilars
S5 Ep12: Biosimilars Regulatory Roundup for November 2022—Podcast Edition
Listen
Description
Show notes
Rezvoglar Becomes Second Interchangeable Insulin Biosimilar
Biosimilar Business Recap: Progress for Insulin in Europe, Canada; Biocon Biologics' Viatris Acquisition Completed
The European Union Gains Another Ranibizumab Biosimilar
Alvotech Snags Australian Approval for Adalimumab Biosimilar
Biosimilar Check-in: PBM to Cover Adalimumab Biosimilars; World’s First Denosumab Biosimilar; Organon Launches in Canada
Senator Introduces Bill to Rid Switching Study Requirements for Interchangeability
BioRationality: A Dr Sarfaraz Niazi Column—FDA Launches Biosimilar Regulatory Science Program
AAM's Craig Burton: Is the Biden Administration Doing Enough to Help Biosimilars?
podcast
details
Print
Share
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
Check it
This website doesn't track the visitors or use any cookies. Made by
Alex Barredo
. Send your feedback to
alex@barredo.es
.
